From UCLA
To those who envision the day when physicians will treat patients in a highly tailored fashion, depending on their individual biology and unique aspects of their disease, a $35,000 research project holds intriguing promise. That's what it cost Bruin researchers in less than a month to figure out the genetic sequence -- the sui generis signature, if you will -- of a much-studied brain cancer. That compares with the decades of work by hundreds of researchers at a cost of billions of dollars to undertake the breakthrough science that produced the sequence of the human geonome. With the latest data in hand, researchers say they can better treat this form of brain cancer, targeting therapies and determining crucial elements of the disease, such as knowing much earlier its possible recurrence and figuring if and when often harsh measures can be halted because the cancer, effectively, has been killed.
Genetic sequencing will let doctors target treatment, know of cancer's recurrence, defeat
Comments